CEA, CAP-1-6-D, [Asp⁶]-Carcinoembryonic Antigen is a modified epitope fragment used to explore structural impacts of residue substitution. Its sequence supports β-turn analysis and surface-exposure mapping. Researchers evaluate how aspartate insertion alters motif orientation. The molecule aids refined CEA structural studies.
CAT No: C08075
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.